Activation of the prostaglandin EP4-receptor subtype is highly coupled to inhibition of N-formyl-methionyl-leucyl-phenylalanine-stimulated rat neutrophil aggregation

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 58, Issue 1, 1998, Pages 77-84

  Wise, H ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

7 [5 (4 BIPHENYLYLMETHOXY) 2 MORPHOLINO 3 OXOCYCLOPENTYL] 4 HEPTENOIC ACID; ADENYLATE CYCLASE; CYCLIC AMP; FORMYLMETHIONYLLEUCYLPHENYLALANINE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; THROMBOCYTE ACTIVATING FACTOR; 2 PYRROLIDONE DERIVATIVE; BIPHENYL DERIVATIVE; CICAPROST; DRUG DERIVATIVE; PHOSPHODIESTERASE INHIBITOR; PROSTACYCLIN; PROSTAGLANDIN E2; ROLIPRAM;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; LEUKOCYTE AGGREGATION; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR BLOCKING; ANIMAL; CELL AGGREGATION; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALIA;

ANIMALS; BIPHENYL COMPOUNDS; CELL AGGREGATION; CYCLIC AMP; DINOPROSTONE; EPOPROSTENOL; MALE; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; PHOSPHODIESTERASE INHIBITORS; PLATELET ACTIVATING FACTOR; PYRROLIDINONES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROSTAGLANDIN E; ROLIPRAM;

EID: 0031594689     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(98)90133-8     Document Type: Article

References (26)

1. Wheeldon A., Vardey C. J. Characterization of the inhibitory prostanoid receptors on human neutrophils, Br J Pharmacol 1993; 108: 1051-1054.
2. Wise H., Jones R. L. Characterization of prostanoid receptors on rat neutrophils. Br J Pharmacol 1994; 113: 581-587.
3. 2 and selective EP agonists on chemotaxis of human neutrophils. Br J Pharmacol 1995; 116: 2903-2908.
4. Talpain E., Armstrong R. A., Coleman R. A., Vardey C. Characterization of the PGE receptor subtype mediating inhibition of superoxide production in human neutrophils. Br J Pharmacol 1995; 114: 1459-1465.
5. Coleman R. A., Grix S. P., Head S. A., Louttit J. B., Mallett A., Sheldrick R. L. G. A novel inhibitory prostanoid receptor in piglet saphenous vein. Prostaglandins 1994; 47: 151-168.
6. Coleman R. A., Smith W. L, Narumiya S. International Union of Pharmacology classification of prostanoid receptors: Properties, distribution and structure of the receptors and their subtypes. Pharmacol Rev 1994; 46: 205-229.
7. 2 subtype. J Biol Chem 1993; 268: 7759-7762.
8. 2 subtype. J Biol Chem 1994; 269: 11873-11877.
9. Regan J. W., Bailey T. J., Pepperl D. J. et al. Cloning of a novel human prostaglandin receptor with charateristics of the pharmacologically defined EP2 subtype. Mol Pharmacol 1994; 46: 213-220.
10. 2 subtype. Biochem Biophys Res Commun 1994; 200: 1329-1333.
11. 2 subtype: cloning, expression, and Northern blot analysis. FEBS Lett 1995; 372: 151-156.
12. Breyer R. M., Davis L S., Nian C. et al. Cloning and expression of the rabbit prostaglandin EP4 receptor. Am J Phystol 1996; 270: F485-F493.
13. Nishigaki N., Negishi M., Honda A. et al. Identification of prostaglandin E receptor 'EP2' cloned from mastocytoma cells as EP4 subtype. FEBS Lett 1995; 364: 339-341.
14. Salomon Y., Londos C., Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem 1974; 58: 541-548.
15. 2 on rat neutrophil aggregation. J Leukoc Biol 1996; 60: 480-486.
16. Chijiwa T., Mishima A., Hagiwara M. et al. Inhibition of forskolin-induced neurite and protein phosphorylation by a newly synthesized inhibitor of cAMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromcytoma cells. J Biol Chem 1990; 265: 5267-5272.
17. Wise H. The inhibitory effects of non-prostanoid prostacyclin mimetics on rat neutrophil function. Prostaglandins Leukot Essent Fatty Acids 1996; 54: 351-360.
18. Kenakin T. P. The quantification of relative efficacy of agonists. J Pharmacological Methods 1985; 13: 281-308.
19. Gryglewski R. J., Salvemini D. Modulation of polymorphonuclear leukocyte function by prostaglandins and nitric oxide. In: Rubanyi, G.M., Vane, J., eds. Prostacyclin: New Perspectives for Basic Research and Novel Therapeutic Indications. Elsevier Science Publishers, 1992: 59-92.
20. 2. Circ 1985; 72: 1208-1218.
21. Lydford S. J., McKechnie K. C. W., Dougall I. G. Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery. Br J Pharmacol 1996; 117: 13-20.
22. 4 receptors positively coupled to adenylate cyclase. Br J Pharmacol 1994; 113: 8P.
23. Armstrong R. A., Talpain E. Comparison of the prostaglandin E (EP) receptor of human neutrophils and HL-60 cells. Prostaglandins 1994; 48: 221-234.
24. De Vries G. W., Guarino P., McLaughlin A., Chen J., Andrews S., Woodward D. F. An EP receptor with a novel pharmacological profile in the T-cell line Jurkat. Br J Pharmacol 1995; 115: 1231-1234.
25. Milne S., Armstrong R. A., Woodward D. Investigation of the ability of selective EP-agonists to inhibit superoxide anion generation in human monocytes. Br J Pharmacol 1995; 116: 321P.
26. Lumley P. AH-23848. Drugs of the Future 1986; 11: 85-88.